Veracyte VCYT Enterprise value

Enterprise value at other companies

Myriad GeneticsMYGN

$506.29M-41.6%

Biodesix, Inc.BDSX

$275.32M+200%

Castle BiosciencesCSTL

$702.86M+38.6%

Personalis, Inc.PSNL

$631.91M+125%

Guardant HealthGH

$12.72B+121%

Natera, Inc.NTRA

$38.02B+67.8%

FAQ

What is Veracyte's enterprise value?

Veracyte (VCYT) reported enterprise value of $2.33B in Q1 2026.

How has Veracyte's enterprise value changed year-over-year?

Veracyte's enterprise value increased by 7.4% year-over-year, from $2.17B to $2.33B.

What is the long-term trend for Veracyte's enterprise value?

Over 5 years (2020 to 2025), Veracyte's enterprise value has grown at a -0.9% compound annual growth rate (CAGR), from $3.14B to $3B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.